Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1994 Jul;38(7):1515-8.
doi: 10.1128/AAC.38.7.1515.

Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus

Affiliations
Comparative Study

Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus

D P Nicolau et al. Antimicrob Agents Chemother. 1994 Jul.

Abstract

The purpose of this study was to determine the penetration of minocycline and vancomycin into cardiac vegetations and to determine their efficacy in a rabbit model of endocarditis caused by oxacillin-resistant Staphylococcus aureus. Animals were randomized into three groups: control (no antibiotic), minocycline (6 mg/kg given intravenously every 8 h), and vancomycin (50 mg/kg given intravenously every 8 h). Penetration of the antibiotics into aortic valve vegetations was determined by using the tissue/serum area under the concentration-time curve ratio. The reductions in the bacterial density of the vegetations caused by both vancomycin (4.8 +/- 1.2 CFU/g) and minocycline (5.3 +/- 1.6 CFU/g) were significantly different from that of controls (8.7 +/- 1.8 CFU/g). Although the penetration of minocycline was twice that of vancomycin, they were equally effective in reducing the bacterial density of the vegetations, since the concentrations of both agents in tissue remained above their MICs for oxacillin-resistant S. aureus. For organisms for which the MICs are higher, however, these penetration differences may result in treatment differences.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Med Sci. 1968 Mar;255:179-95 - PubMed
    1. Antimicrob Agents Chemother. 1974 Oct;6(4):411-4 - PubMed
    1. J Antimicrob Chemother. 1981 Jul;8(1):39-48 - PubMed
    1. Antimicrob Agents Chemother. 1985 Nov;28(5):607-11 - PubMed
    1. Kansenshogaku Zasshi. 1986 Aug;60(8):911-6 - PubMed

Publication types

MeSH terms